We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Invesco (IVZ) Aided by Robust AUM Amid a Fall in Revenues
Read MoreHide Full Article
Invesco Ltd. (IVZ - Free Report) is benefiting from its robust assets under management (AUM) balance, diversified product offerings and global presence. Synergies from strategic buyouts and manageable expense levels will also likely keep aiding the company’s profitability. Yet, a challenging operating environment is expected to hurt its top-line growth.
Looking at the fundamentals, Invesco’s total operating expenses have witnessed a negative compound annual growth rate (CAGR) of 4.8% over the last three years ended 2022. The trend persisted in the first quarter of 2023. Further, Invesco exceeded its target of realizing net cost synergies from the OppenheimerFunds acquisition and also achieved annualized net savings well ahead of schedule.
As the company's inorganic growth efforts, technology upgrades and inflation are likely to put pressure on expenses, we expect total expenses (adjusted) to witness a marginal rise this year.
Though the total AUM balance declined in 2022, the same witnessed a CAGR of 2.2% over the last three years ended 2022. The acquisition of OppenheimerFunds primarily resulted in the rise in the company's AUM. The uptrend continued on a sequential basis in the first quarter of 2023.
Further, IVZ has been capitalizing on the growing demand for passive products and alternate asset classes, which were 32.2% and 12.5% of total AUM, respectively, on Mar 31, 2023. We project passive AUM and alternate asset class AUM balance to witness a CAGR of 8.2% and 8.9%, respectively, by 2025.
Apart from a strong presence in the United States, Invesco maintains a solid foothold in Europe, Canada and the Asia-Pacific. As of Mar 31, 2023, the company's client AUM outside the United States constituted almost 29% of the total AUM. Acquisitions of Intelliflo, along with Europe-based Source, have improved market share globally and continue to support its global presence. These and other broad diversification efforts will likely help the company to generate further momentum from business in such regions.
Further, analysts are optimistic about the stock’s earnings prospects. The Zacks Consensus Estimate for IVZ's 2023 earnings has been revised marginally upward over the past 30 days. The company currently carries a Zacks Rank #3 (Hold).
In the past three months, shares of IVZ have gained 8.6% compared with the industry's 11.8% upside.
Image Source: Zacks Investment Research
However, total operating revenues witnessed a six-year (2017-2022) CAGR of 3.2% on a solid AUM balance and the OppenheimerFunds buyout, it has been recording a downtrend since the second half of 2020. Despite having a robust institutional pipeline, diverse product offerings and alternative investment strategies, solid retail channels, and synergies from opportunistic acquisitions, revenues are likely to be under pressure in the near term. We anticipate operating revenues to decline 4.7% in 2023.
As of Mar 31, 2023, the company’s goodwill and net intangible assets remained considerably high, totaling $15.7 billion (52.9% of total assets). Several factors may initiate the impairment of the book value of such assets, due to which their value may have to be written down. This is likely to affect the company's financials.
Finance Stocks Worth a Look
A couple of better-ranked stocks from the finance space are HomeTrust Banshares, Inc. and Pathward Financial, Inc. (CASH - Free Report) .
The Zacks Consensus Estimate for HomeTrust Banshares’ current-year earnings has been revised 7.7% upward over the past 60 days. Its shares have gained 9.2% in the past month. Currently, HTBI carries a Zacks Rank #2 (Buy).
Pathward Financial currently carries a Zacks Rank #2. The consensus mark for the company's 2023 earnings has been revised 1.8% upward over the past 60 days. In the past six months, CASH shares have rallied 13.5%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Invesco (IVZ) Aided by Robust AUM Amid a Fall in Revenues
Invesco Ltd. (IVZ - Free Report) is benefiting from its robust assets under management (AUM) balance, diversified product offerings and global presence. Synergies from strategic buyouts and manageable expense levels will also likely keep aiding the company’s profitability. Yet, a challenging operating environment is expected to hurt its top-line growth.
Looking at the fundamentals, Invesco’s total operating expenses have witnessed a negative compound annual growth rate (CAGR) of 4.8% over the last three years ended 2022. The trend persisted in the first quarter of 2023. Further, Invesco exceeded its target of realizing net cost synergies from the OppenheimerFunds acquisition and also achieved annualized net savings well ahead of schedule.
As the company's inorganic growth efforts, technology upgrades and inflation are likely to put pressure on expenses, we expect total expenses (adjusted) to witness a marginal rise this year.
Though the total AUM balance declined in 2022, the same witnessed a CAGR of 2.2% over the last three years ended 2022. The acquisition of OppenheimerFunds primarily resulted in the rise in the company's AUM. The uptrend continued on a sequential basis in the first quarter of 2023.
Further, IVZ has been capitalizing on the growing demand for passive products and alternate asset classes, which were 32.2% and 12.5% of total AUM, respectively, on Mar 31, 2023. We project passive AUM and alternate asset class AUM balance to witness a CAGR of 8.2% and 8.9%, respectively, by 2025.
Apart from a strong presence in the United States, Invesco maintains a solid foothold in Europe, Canada and the Asia-Pacific. As of Mar 31, 2023, the company's client AUM outside the United States constituted almost 29% of the total AUM. Acquisitions of Intelliflo, along with Europe-based Source, have improved market share globally and continue to support its global presence. These and other broad diversification efforts will likely help the company to generate further momentum from business in such regions.
Further, analysts are optimistic about the stock’s earnings prospects. The Zacks Consensus Estimate for IVZ's 2023 earnings has been revised marginally upward over the past 30 days. The company currently carries a Zacks Rank #3 (Hold).
In the past three months, shares of IVZ have gained 8.6% compared with the industry's 11.8% upside.
Image Source: Zacks Investment Research
However, total operating revenues witnessed a six-year (2017-2022) CAGR of 3.2% on a solid AUM balance and the OppenheimerFunds buyout, it has been recording a downtrend since the second half of 2020. Despite having a robust institutional pipeline, diverse product offerings and alternative investment strategies, solid retail channels, and synergies from opportunistic acquisitions, revenues are likely to be under pressure in the near term. We anticipate operating revenues to decline 4.7% in 2023.
As of Mar 31, 2023, the company’s goodwill and net intangible assets remained considerably high, totaling $15.7 billion (52.9% of total assets). Several factors may initiate the impairment of the book value of such assets, due to which their value may have to be written down. This is likely to affect the company's financials.
Finance Stocks Worth a Look
A couple of better-ranked stocks from the finance space are HomeTrust Banshares, Inc. and Pathward Financial, Inc. (CASH - Free Report) .
The Zacks Consensus Estimate for HomeTrust Banshares’ current-year earnings has been revised 7.7% upward over the past 60 days. Its shares have gained 9.2% in the past month. Currently, HTBI carries a Zacks Rank #2 (Buy).
Pathward Financial currently carries a Zacks Rank #2. The consensus mark for the company's 2023 earnings has been revised 1.8% upward over the past 60 days. In the past six months, CASH shares have rallied 13.5%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.